Frontiers in Hematology is a peer-reviewed english-language open-access journal published by Frontiers Media S.A. in Switzerland, operating under an open-access model since 2022. The journal covers Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens.
Authors are required to pay an article processing charge to publish in Frontiers in Hematology; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY license (see other journals using this license).
Keywords
hematology, haematological tumours, genetic immunology, stem cells, cancer therapy
At a glance
- Publisher
- Frontiers Media S.A.
- Country
- Switzerland
- Primary language
- English
- License
- CC BY
- Peer review
- Anonymous peer review
- OA since
- 2022
ISSN
- electronic
- 2813-3935
Frequently asked questions
Is Frontiers in Hematology peer-reviewed?
Yes — Frontiers in Hematology operates a Anonymous peer review review process.
Does Frontiers in Hematology charge an article processing charge (APC)?
Yes — refer to the journal's APC page for the current rate. A waiver policy is available for eligible authors.
What subjects does Frontiers in Hematology publish?
Frontiers in Hematology publishes research in Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens.
What languages does Frontiers in Hematology accept?
Frontiers in Hematology accepts manuscripts in English.
What is the ISSN of Frontiers in Hematology?
ISSN:
2813-3935 (electronic).How do I submit a manuscript to Frontiers in Hematology?
Submit through the journal's official portal: visit submission page →